Axsome Therapeutics Inc (AXSM)

01:46 AM

Axsome: Some Recent Setbacks, Some Recent Wins — Still A Buy (NASDAQ:AXSM) - Seeking Alpha

01:46 AM

12:56 PM

Axsome Therapeutics (NASDAQ:AXSM) Trading Down 5.6%Time to Sell? - MarketBeat

12:56 PM

08:08 AM

Why Axsome Therapeutics Inc. stock is on top investor watchlistsSuperior stock selection - jammulinksnews.com

08:08 AM

07:22 AM

What analysts say about Axsome Therapeutics Inc. stockOutstanding capital growth - Autocar Professional

07:22 AM

03:38 AM

Axsome Therapeutics Inc. Stock Analysis and ForecastRapid growth trajectories - PrintWeekIndia

03:38 AM

Jul 24, 2025

RBC Capital Sticks to Their Buy Rating for Axsome Therapeutics (AXSM) - The Globe and Mail

Jul 24, 2025

Jul 24, 2025

New York State Common Retirement Fund Has $3.92 Million Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 24, 2025

Jul 24, 2025

Is Axsome Therapeutics Inc. stock overhyped or has real potentialUnstoppable trading performance - jammulinksnews.com

Jul 24, 2025

Jul 24, 2025

How high can Axsome Therapeutics Inc. stock price go in 2025Breakthrough investment results - jammulinksnews.com

Jul 24, 2025

Jul 24, 2025

How To Trade (AXSM) - news.stocktradersdaily.com

Jul 24, 2025

Jul 24, 2025

Y Intercept Hong Kong Ltd Purchases New Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 24, 2025

Jul 24, 2025

Is This Stock a Buy After Soaring by 20% in 1 Day? - AOL.com

Jul 24, 2025

Jul 24, 2025

2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now - MSN

Jul 24, 2025

Jul 24, 2025

William Blair Issues Positive Forecast for AXSM Earnings - MarketBeat

Jul 24, 2025

Jul 24, 2025

Legato Capital Management LLC Buys New Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 24, 2025

Jul 24, 2025

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Stock Position Increased by Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. - MarketBeat

Jul 24, 2025

Jul 24, 2025

Is Axsome Therapeutics Inc. a good long term investmentGame-changing returns - Autocar Professional

Jul 24, 2025

Jul 23, 2025

Leerink Partners Keeps Bullish Stance on Axsome Therapeutics with Buy Rating - AInvest

Jul 23, 2025

Jul 23, 2025

Optimistic Outlook for Axsome Therapeutics: Promising Pipeline and Potential Sales Growth Drive Buy Rating - TipRanks

Jul 23, 2025

Jul 22, 2025

Axsome Therapeutics Breaks Below 200-Day Moving AverageNotable for AXSM - Nasdaq

Jul 22, 2025

Jul 22, 2025

What drives Axsome Therapeutics Inc. stock priceUnprecedented profit potential - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Readystate Asset Management LP Invests $6.95 Million in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 22, 2025

Jul 22, 2025

ALKS Down Despite Positive Top-Line Data From Narcolepsy Study - The Globe and Mail

Jul 22, 2025

Jul 22, 2025

Axsome Therapeutics stock rating reiterated by Cantor Fitzgerald - Investing.com Canada

Jul 22, 2025

Jul 22, 2025

Mizuho reiterates Outperform rating on Axsome Therapeutics stock By Investing.com - Investing.com South Africa

Jul 22, 2025

Jul 22, 2025

Axsome Therapeutics: Promising Growth Driven by Robust Pipeline and Strategic Fit - TipRanks

Jul 22, 2025

Jul 22, 2025

Lindbrook Capital LLC Sells 14,103 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 22, 2025

Jul 21, 2025

Axsome Therapeutics Rings the Opening Bell - Nasdaq

Jul 21, 2025

Jul 21, 2025

Axsome Therapeutics hosts frontiers in Brain Health R&D Day - TipRanks

Jul 21, 2025

Jul 21, 2025

Axsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS Pipeline - Lelezard

Jul 21, 2025

Jul 21, 2025

Axsome Therapeutics: A CNS Pipeline with High-Impact Catalysts for Long-Term Growth - AInvest

Jul 21, 2025

Jul 21, 2025

Axsome Therapeutics Hosts R&D Day to Present Comprehensive Data on CNS Pipeline Targeting Alzheimer’s Disease, Depression, Narcolepsy, Fibromyalgia, ADHD, and Smoking Cessation - Nasdaq

Jul 21, 2025

Jul 21, 2025

Axsome Reveals New Phase 3 Data for 6 Major Brain Disorders: Expert Panel Discusses Breakthrough Treatments - Stock Titan

Jul 21, 2025

Jul 21, 2025

Axsome Celebrates New CNS Drug Launch with NASDAQ Bell Ringing, Unveils Brain Health Pipeline - Stock Titan

Jul 21, 2025

Jul 20, 2025

Bank of New York Mellon Corp Has $15.28 Million Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 20, 2025

Jul 20, 2025

William Blair Issues Negative Outlook for AXSM Earnings - MarketBeat

Jul 20, 2025

Jul 19, 2025

Analysts Are Bullish on These Healthcare Stocks: Axsome Therapeutics (AXSM), Enliven Therapeutics (ELVN) - The Globe and Mail

Jul 19, 2025

Jul 18, 2025

Mizuho reiterates Outperform rating on Axsome Therapeutics stock ahead of R&D Day - Investing.com Australia

Jul 18, 2025